Publications by authors named "Urs Sprecher"

Claim this Profile
D
Discovery and optimisation of 1-hydroxyimino-3,3-diphenylpropanes, a new class of orally active GPBAR1 (TGR5) agonists.
Henrietta Dehmlow, Rubén Alvarez Sánchez, Stephan Bachmann, Caterina Bissantz, Fritz Bliss, Urs Sprecher

Bioorg Med Chem Lett· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of carmegliptin: a potent and long-acting dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes.
Patrizio Mattei, Markus Boehringer, Patrick Di Giorgio, Holger Fischer, Michael Hennig, Urs Sprecher

Bioorg Med Chem Lett· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aryl- and heteroaryl-substituted aminobenzo[a]quinolizines as dipeptidyl peptidase IV inhibitors.
Markus Boehringer, Holger Fischer, Michael Hennig, Daniel Hunziker, Joerg Huwyler, Urs Sprecher

Bioorg Med Chem Lett· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel, non-peptidic somatostatin receptor subtype 5 antagonists improve glucose tolerance in rodents.
Urs Sprecher, Peter Mohr, Rainer E Martin, Hans Peter Maerki, Rubén Alvarez Sanchez

Regul Pept· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis